RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Very difficult to be constructiveEngage them with what???? Buy our stock, but all we have to sell for now is hope that it will work some day? Time for hope is well passed for Thera. They need strong results to be able to convince new investors and they cannot disclose important material infos to selected investors. That being said, they can do it under confidentiality agreements with potential partners. But if what they see now shows a proof of concept, they are better to wait before signing a partnership. They have enough money to run the phase Ib. At this point info release is highly strategic from a financing point of view. If they have something, a likely proof of concept, they need to play their cards properly. But with covid, now with the war in Ukraine, it's a moving landscape. Not the easiest situation.
Scioto1 wrote:
If you read through my thread you'll see that I acknowledge that our clinical work and project development is critical. But I think it's Also an important responsibility of management to engage shareholders, engage potential institutional investors, engage analysts, and advance a public information campaign plan all with an eye towards shareholder value. I'm not talking about creating it out of thin air. It needs to be an important priority just like the research and development.